What is EuroBiotix?
EuroBiotix is a multi-award winning biotechnology enterprise dedicated to the therapeutic potential of the human gut microbiome. The company specializes in the development and distribution of standardized, unlicensed medicinal products designed to facilitate Faecal Microbiota Transplantation. By translating cutting-edge scientific research into practical, clinical-grade solutions, EuroBiotix empowers medical professionals to treat complex conditions through the modulation of beneficial bacteria. Their market position is defined by a commitment to rigorous quality standards and a compassionate, expert-led approach to patient care, aiming to establish a global footprint in the rapidly evolving field of microbiome science.
How much funding has EuroBiotix raised?
EuroBiotix has raised a total of $1.2M across 2 funding rounds:
Grant
$535K
Angel/Seed
$632K
Grant (2016): $535K, investors not publicly disclosed
Angel/Seed (2017): $632K led by Equity Gap
Key Investors in EuroBiotix
Equity Gap
Equity Gap is a Scottish investment firm specializing in high-growth, early-stage businesses across diverse sectors, including life sciences and industrial technology. They provide critical capital and strategic support to emerging ventures while maintaining regulatory compliance with the Financial Conduct Authority.
Undisclosed Investor
Undisclosed investor participating in the funding round.
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for EuroBiotix?
With this major strategic investment, EuroBiotix is poised to accelerate its clinical development pipeline and expand its manufacturing capabilities. The company's forward-looking strategy focuses on the refinement of its personalized FMT tools, which are essential for precision medicine in gastroenterology and beyond. As the firm transitions into a more mature operational phase, the focus will likely shift toward regulatory milestones and the scaling of its distribution network to meet the growing global demand for microbiome-based therapies. By maintaining its focus on high-impact research and clinical excellence, EuroBiotix is well-positioned to lead the next wave of innovation in gut health and therapeutic intervention.
See full EuroBiotix company page
